These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17702597)

  • 1. Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro.
    Rossi L; Bonmassar E; Faraoni I
    Pharmacol Res; 2007 Sep; 56(3):248-53. PubMed ID: 17702597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
    Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
    Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
    Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
    J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY; Lee JS; Min HY; Lee HY
    Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21-mediated regulation of Sprouty2 protein expression enhances the cytotoxic effect of 5-fluorouracil and metformin in colon cancer cells.
    Feng YH; Wu CL; Shiau AL; Lee JC; Chang JG; Lu PJ; Tung CL; Feng LY; Huang WT; Tsao CJ
    Int J Mol Med; 2012 May; 29(5):920-6. PubMed ID: 22322462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.
    Deng J; Lei W; Fu JC; Zhang L; Li JH; Xiong JP
    Biochem Biophys Res Commun; 2014 Jan; 443(3):789-95. PubMed ID: 24275137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells.
    Zhao HY; Ooyama A; Yamamoto M; Ikeda R; Haraguchi M; Tabata S; Furukawa T; Che XF; Iwashita K; Oka T; Fukushima M; Nakagawa M; Ono M; Kuwano M; Akiyama S
    Cancer Lett; 2008 Oct; 270(1):156-63. PubMed ID: 18583030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
    Li X; Zhao H; Zhou X; Song L
    Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1.
    Wan LY; Deng J; Xiang XJ; Zhang L; Yu F; Chen J; Sun Z; Feng M; Xiong JP
    Biochem Biophys Res Commun; 2015 Feb; 457(2):125-32. PubMed ID: 25446103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil.
    Pranzini E; Leo A; Rapizzi E; Ramazzotti M; Magherini F; Giovannelli L; Caselli A; Cirri P; Taddei ML; Paoli P
    Mol Carcinog; 2019 Dec; 58(12):2181-2192. PubMed ID: 31468617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer.
    Chen J; Chen Y; Chen Z
    Cancer Invest; 2013 Jan; 31(1):17-23. PubMed ID: 23327190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells.
    Shah MY; Pan X; Fix LN; Farwell MA; Zhang B
    J Cell Physiol; 2011 Jul; 226(7):1868-78. PubMed ID: 21506117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
    Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.